Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 150 of 341 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/17/21
End: 11/05/22
Due: 11/05/23
Phase: N/A
Priority: Normal
Start: 01/01/99
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/24/25
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 07/01/26
Due: 07/01/27
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 07/01/26
Due: 07/01/27
Phase: N/A
Priority: Normal
Start: 06/05/23
End: 06/01/27
Due: 06/01/28
Phase: N/A
Priority: Normal
Start: 11/05/18
End: 05/04/23
Due: 05/04/24
Phase: N/A
Priority: Normal
Start: 04/05/22
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 02/27/20
End: 05/27/22
Due: 05/27/23
SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Phase: N/A
Priority: Normal
Start: 03/10/24
End: 07/30/26
Due: 07/30/27
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 02/21/25
End: 03/21/27
Due: 03/21/28
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: 02/17/21
End: 08/10/23
Due: 08/10/24
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 10/28/24
Due: 10/28/25